相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
Yusuf Dolen et al.
ONCOIMMUNOLOGY (2016)
Vaccine adjuvants as potential cancer immunotherapeutics
Burcu Temizoz et al.
INTERNATIONAL IMMUNOLOGY (2016)
Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses
Hyon-Xhi Tan et al.
VACCINE (2016)
Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens
Jerome Le Nours et al.
NATURE COMMUNICATIONS (2016)
T Cell Help Amplifies Innate Signals in CD8+ DCs for Optimal CD8+ T Cell Priming
Marie Greyer et al.
CELL REPORTS (2016)
α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
Bianca L. Artiaga et al.
SCIENTIFIC REPORTS (2016)
Synthesis of C-5 and C-6-modified α-GalCer analogues as iNKT-cell agonists
Joren Guillaume et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions
Sarah Eickhoff et al.
CELL (2015)
Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection
Jyh Liang Hor et al.
IMMUNITY (2015)
Identification of a Potent Microbial Lipid Antigen for Diverse NKT Cells
Benjamin J. Wolf et al.
JOURNAL OF IMMUNOLOGY (2015)
Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming
Taryn L. Osmond et al.
JOURNAL OF IMMUNOLOGY (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Engineering opportunities in cancer immunotherapy
Laura Jeanbart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8+ T-cell responses and prevent tumour progression
Silke Neumann et al.
VACCINE (2015)
Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials
Isabel Leroux-Roels et al.
VACCINE (2015)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
Geert Leroux-Roels et al.
VACCINE (2015)
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity
Regan J. Anderson et al.
CHEMICAL SCIENCE (2015)
Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help
Juhyun Kim et al.
NATURE COMMUNICATIONS (2015)
The Regulatory Role of Invariant NKT Cells in Tumor Immunity
Rosanna M. McEwen-Smith et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Cancer vaccine adjuvants - recent clinical progress and future perspectives
Abid H. Banday et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2015)
An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment
John D. Gibbins et al.
BLOOD (2014)
Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy
M. Singh et al.
BRITISH JOURNAL OF CANCER (2014)
iNKT-cell help to B cells: A cooperative job between innate and adaptive immune responses
Paolo Dellabona et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
A Single Subset of Dendritic Cells Controls the Cytokine Bias of Natural Killer T Cell Responses to Diverse Glycolipid Antigens
Pooja Arora et al.
IMMUNITY (2014)
IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset
Duygu Sag et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Age-Related Decrease in TCR Repertoire Diversity Measured with Deep and Normalized Sequence Profiling
Olga V. Britanova et al.
JOURNAL OF IMMUNOLOGY (2014)
Antigen-Dependent versus -Independent Activation of Invariant NKT Cells during Infection
Keli L. Holzapfel et al.
JOURNAL OF IMMUNOLOGY (2014)
Immunosuppressive roles of natural killer T (NKT) cells in the skin
Sara J. McKee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
VACCINE DEVELOPMENT NKT-cell adjuvants in conjugate
Paul B. Savage
NATURE CHEMICAL BIOLOGY (2014)
A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
Regan J. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
A semisynthetic carbohydrate-lipid vaccine that protects against S-pneumoniae in mice
Marco Cavallari et al.
NATURE CHEMICAL BIOLOGY (2014)
Improving Mycobacterium bovis Bacillus Calmette-Guerin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells
Manjunatha M. Venkataswamy et al.
PLOS ONE (2014)
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
Josianne Nitcheu Tefit et al.
VACCINE (2014)
Inclusion of a universal tetanus toxoid CD4+ T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines
Xiaobo Wen et al.
VACCINE (2014)
Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates
Christopher C. Fraser et al.
VACCINE (2014)
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
Jaap T. van Dissel et al.
VACCINE (2014)
Adjuvant effects of therapeutic glycolipids administered to a cohort of NKT cell-diverse pigs
Bianca L. Artiaga et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2014)
Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
James L. Gulley et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Vaccination with Antigen-Transfected, NKT Cell Ligand-Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells
Kanako Shimizu et al.
CANCER RESEARCH (2013)
In-vivo stimulation of macaque natural killer T cells with -galactosylceramide
C. S. Fernandez et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy
Robert Weinkove et al.
HAEMATOLOGICA (2013)
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
Mark T. Orr et al.
JOURNAL OF CONTROLLED RELEASE (2013)
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
Heather M. Long et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The Mechanism of Splenic Invariant NKT Cell Activation Dictates Localization In Vivo
Irah L. King et al.
JOURNAL OF IMMUNOLOGY (2013)
Invariant NKT Cells Induce Plasmacytoid Dendritic Cell (DC) Cross-Talk with Conventional DCs for Efficient Memory CD8+ T Cell Induction
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2013)
The role of invariant natural killer T cells in microbial immunity
Yuki Kinjo et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides
Li Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Toll-like Receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes
Tatsuya Ando et al.
SCIENTIFIC REPORTS (2013)
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
Stephen R. Mattarollo et al.
BLOOD (2012)
Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival
Marie-Therese Rubio et al.
BLOOD (2012)
Vaccination with Irradiated Tumor Cells Pulsed with an Adjuvant That Stimulates NKT Cells Is an Effective Treatment for Glioma
Martin K. Hunn et al.
CLINICAL CANCER RESEARCH (2012)
The location of splenic NKT cells favours their rapid activation by blood-borne antigen
Patricia Barral et al.
EMBO JOURNAL (2012)
Turned on by danger: activation of CD1d-restricted invariant natural killer T cells
Victoria Lawson
IMMUNOLOGY (2012)
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway
Nicholas S. Wilson et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
Famke L. Schneiders et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses
Sara J. McKee et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Follicular Helper NKT Cells Induce Limited B Cell Responses and Germinal Center Formation in the Absence of CD4+ T Cell Help
Elena Tonti et al.
JOURNAL OF IMMUNOLOGY (2012)
Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses
Pheh-Ping Chang et al.
NATURE IMMUNOLOGY (2012)
Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner
Irah L. King et al.
NATURE IMMUNOLOGY (2012)
Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity
Sebastian Zeissig et al.
NATURE MEDICINE (2012)
Saposins utilize two strategies for lipid transfer and CD1 antigen presentation
Luis Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunomodulatory Type II Natural Killer T Lymphocytes in Health and Disease
S. Rhost et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Viral Vector-Based Therapeutic Cancer Vaccines
Cecilia Larocca et al.
CANCER JOURNAL (2011)
Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Andrew J. Nicol et al.
CLINICAL CANCER RESEARCH (2011)
Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection
Famke L. Schneiders et al.
CLINICAL IMMUNOLOGY (2011)
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
Kazuki Yamasaki et al.
CLINICAL IMMUNOLOGY (2011)
Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation
Seth T. Scanlon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I IFN Substitutes for T Cell Help during Viral Infections
Melanie Wiesel et al.
JOURNAL OF IMMUNOLOGY (2011)
NKT Cells Inhibit Antigen-Specific Effector CD8 T Cell Induction to Skin Viral Proteins
Stephen R. Mattarollo et al.
JOURNAL OF IMMUNOLOGY (2011)
A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties
Adam P. Uldrich et al.
NATURE IMMUNOLOGY (2011)
Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+T Cells to Dendritic Cell-Based Vaccines
Troels R. Petersen et al.
PLOS ONE (2011)
The Shedding of CD62L (L-Selectin) Regulates the Acquisition of Lytic Activity in Human Tumor Reactive T Lymphocytes
Shicheng Yang et al.
PLOS ONE (2011)
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
Megan K. L. MacLeod et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors
Jessica B Lee et al.
Immunity & Ageing (2011)
Presumed guilty: natural killer T cell defects and human disease
Stuart P. Berzins et al.
NATURE REVIEWS IMMUNOLOGY (2011)
CD1d-Dependent B-Cell Help by NK-Like T Cells Leads to Enhanced and Sustained Production of Bacillus anthracis Lethal Toxin-Neutralizing Antibodies
T. Scott Devera et al.
INFECTION AND IMMUNITY (2010)
Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation
Tomonori Iyoda et al.
INTERNATIONAL IMMUNOLOGY (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN-γ Production
Stephen R. Mattarollo et al.
JOURNAL OF IMMUNOLOGY (2010)
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
Gerhard Wingender et al.
JOURNAL OF IMMUNOLOGY (2010)
CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes
Patricia Barral et al.
NATURE IMMUNOLOGY (2010)
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
Verena Semmling et al.
NATURE IMMUNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
NKT-cell help to B lymphocytes can occur independently of cognate interaction
Elena Tonti et al.
BLOOD (2009)
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Jeremy B. Swann et al.
BLOOD (2009)
Cell Death Mechanisms Induced by Cytotoxic Lymphocytes
L. Chavez-Galan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family
A. C. Chan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Immunology of TLR-independent vaccine adjuvants
Ennio De Gregorio et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Mechanism of action of clinically approved adjuvants
Bart N. Lambrecht et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Selective Expression of the Chemokine Receptor XCR1 on Cross-presenting Dendritic Cells Determines Cooperation with CD8+ T Cells
Brigitte G. Dorner et al.
IMMUNITY (2009)
Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells
Hongwei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
NKG2A Inhibits Invariant NKT Cell Activation in Hepatic Injury
Toshihiko Kawamura et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: CD28 Engagement Releases Antigen-Activated Invariant NKT Cells from the Inhibitory Effects of PD-1
Jianxiong Wang et al.
JOURNAL OF IMMUNOLOGY (2009)
Role of Marginal Zone B Lymphocytes in Invariant NKT Cell Activation
Emilie Bialecki et al.
JOURNAL OF IMMUNOLOGY (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
Shinichiro Motohashi et al.
JOURNAL OF IMMUNOLOGY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine
Sarah A. Kopecky-Bromberg et al.
VACCINE (2009)
A clinical grade poly I:C-analogue (Ampligen (R)) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
H. Navabi et al.
VACCINE (2009)
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
David H. Chang et al.
BLOOD (2008)
Vaccination greatly reduces disease, disability, death and inequity worldwide
F. E. Andre et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Synthetic Glycolipid Ligands for Human iNKT Cells as Potential Therapeutic Agents for Immunotherapy
Manabu Araki et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase
Alberto Molano et al.
IMMUNOLOGY LETTERS (2008)
Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus
Eric J. Yager et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IFN-γ-Producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses
Maria Moreno et al.
JOURNAL OF IMMUNOLOGY (2008)
Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses
H. Kamijuku et al.
MUCOSAL IMMUNOLOGY (2008)
NK T cells provide lipid antigen-specific cognate help for B cells
Elizabeth A. Leadbetter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo
Patricia Barral et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide
Yaoxing Huang et al.
VACCINE (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Tetsuro Uchida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production
Gillian A. Lang et al.
BLOOD (2008)
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus
Silvia Vilarinho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell-mediated immunity via dendritic cells
Kanako Shimizu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
An NKT mediated autologous vaccine generates CD4 T-cell-dependent potent antilymphoma immunity
Yeonseok Chung et al.
BLOOD (2007)
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11
Carlos J. Montoya et al.
IMMUNOLOGY (2007)
Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude
James J. Moon et al.
IMMUNITY (2007)
Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood
Yu Jing et al.
EXPERIMENTAL GERONTOLOGY (2007)
A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system
Hyun-Jun Youn et al.
VACCINE (2007)
Invariant NKT cells sustain specific B cell responses and memory
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tumor cells loaded with α-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells
Ian F. Hermans et al.
JOURNAL OF IMMUNOLOGY (2007)
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
Yuki Kinjo et al.
NATURE IMMUNOLOGY (2006)
High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses
Jessica B. Flechtner et al.
JOURNAL OF IMMUNOLOGY (2006)
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4 T cell-dendritic cell interaction
F Castellino et al.
NATURE (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
K Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Increased intratumor Vα24-positive natural killer T cells:: A prognostic factor for primary colorectal carcinomas
T Tachibana et al.
CLINICAL CANCER RESEARCH (2005)
α-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor
SY Ko et al.
JOURNAL OF IMMUNOLOGY (2005)
Glycolipid antigen induces long-term natural killer T cell anergy in mice
VV Parekh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Structure and function of the spleen
RE Mebius et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cell wall glycosphingolipids Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells
V Sriram et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Recognition of bacterial glycosphingolipids by natural killer T cells
Y Kinjo et al.
NATURE (2005)
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
J Mattner et al.
NATURE (2005)
A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
A Ishikawa et al.
CLINICAL CANCER RESEARCH (2005)
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
A Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
M Nieda et al.
BLOOD (2004)
CD1d-restricted T cell activation by nonlipidic small molecules
I Van Rhijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The immunoregulatory role of CD1d-restricted natural killer T cells in disease
HJJ van der Vliet et al.
CLINICAL IMMUNOLOGY (2004)
Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
CM Smith et al.
NATURE IMMUNOLOGY (2004)
Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies
SP Berzins et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
S Oki et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Going both ways: immune regulation via CD1d-dependent NKT cells
DI Godfrey et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection
M Brigl et al.
NATURE IMMUNOLOGY (2003)
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2003)
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function
DB Stetson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells
T Kenna et al.
JOURNAL OF IMMUNOLOGY (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells
LS Metelitsa et al.
LEUKEMIA (2003)
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes
G Galli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Requirement for CD4 T cell help in generating functional CD8 T cell memory
DJ Shedlock et al.
SCIENCE (2003)
Defective CD8 T cell memory following acute infection without CD4 T cell help
JC Sun et al.
SCIENCE (2003)
Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment
JK Sandberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Another view of T cell antigen recognition: Cooperative engagement of glycolipid antigens by Va14Ja18 natural TCR
AK Stanic et al.
JOURNAL OF IMMUNOLOGY (2003)
CD1-dependent dendritic cell instruction
MS Vincent et al.
NATURE IMMUNOLOGY (2002)
A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory
C Bourgeois et al.
SCIENCE (2002)
Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
S Fujii et al.
NATURE IMMUNOLOGY (2002)
Cutting edge:: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice
LT Mars et al.
JOURNAL OF IMMUNOLOGY (2002)
Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines
G Gonzalez-Aseguinolaza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
JE Gumperz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Distinct functional lineages of human Vα-24 natural killer T cells
PT Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
MJ Smyth et al.
BLOOD (2002)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis
AW Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice
R Nakagawa et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2001)
TRAIL expression by activated human CD4+Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells
M Nieda et al.
BLOOD (2001)
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells
EJ Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
